Clinical context Two hours after vaginal birth, a client with active asthma and severe-range blood pressure earlier in labor develops brisk bright-red bleeding, a boggy uterus, hypotension, tachycardia, pallor, and dizziness consistent with uterine-atony postpartum hemorrhage. For each finding, identify the medication-safety implication for oxytocin, tranexamic acid, methylergonovine, or carboprost.
Matrix
Choose your responses, then check the answer.
Explanation
A boggy uterus and brisk bleeding support uterine atony. Severe hypertension makes methylergonovine unsafe, active pulmonary disease makes carboprost unsafe, and birth within 3 hours supports early tranexamic acid in addition to standard care.
Quick answer Separate atony evidence, uterotonic contraindications, and the antifibrinolytic time window.
Why this is correct Tranexamic acid supports clot stability but does not restore uterine tone. The medication plan must address both the atony and ongoing blood loss without ignoring the client-specific contraindications.
Easy analogy or mental picture Use a family-centered medication-safety loop: verify age or pregnancy context, identify the exposure and new cue, prevent further harm, stabilize the client, and confirm the response.
Memory hook Population, indication, dose or route, contraindication, urgent cue, protective action, and reassessment.
NCLEX decision rule Choose the action that protects the maternal, newborn, or pediatric client from the most immediate medication-related harm while preserving authorized treatment.
Why the other choices are wrong Options that normalize a danger sign, substitute an unapproved route or dose, or delay reassessment leave the client exposed to preventable harm.
References
1DailyMed: PITOCIN (oxytocin)Control of postpartum uterine bleeding, uterine response, prolonged-infusion water intoxication, and monitoring
2DailyMed: HEMABATE (carboprost tromethamine)Refractory postpartum hemorrhage due to uterine atony and contraindication in active pulmonary disease
3DailyMed: methylergonovine maleatePostpartum hemorrhage control and contraindication in hypertension or toxemia
4WHO recommendation: tranexamic acid for postpartum hemorrhageEarly intravenous tranexamic acid within 3 hours of birth in addition to standard postpartum hemorrhage care
Clinical contextTwo hours after vaginal birth, a client with active asthma and severe-range blood pressure earlier in labor develops brisk bright-red bleeding, a boggy uterus, hypotension, tachycardia, pallor, and dizziness consistent with uterine-atony postpartum hemorrhage.